CSI Market
Sign In | Register

Lantern Pharma Inc (LTRN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LTRN Annual Balance Sheets →
This balance sheet overview for Lantern Pharma Inc spans from Jun 30 2025 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent6.66
Marketable Securities, Current SH0.70
Cash & Short-term Investments6.00
Other Receivables0.03
Derivatives, Collateral, Regulatory, Deferred0.06
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets8.46
Equipment/Property/Plant Net0.02
Deferred Costs, Noncurrent AS0.05
Other Assets, Noncurrent1.07
Operating Lease Right Of Use Asset0.06
Total Assets8.60
Liabilities
Accounts Payable and Accrued Liabilities, Current LI4.28
Other Liabilities, Current0.04
Total Current Liabilities4.32
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent7.50
Other liabilities, Noncurrent0.00
Operating Lease Liability Noncurrent-
Operating Lease Liability Current0.06
Total Liabilities11.82
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock100.37
Retained Earnings / Accumulated Deficit-103.55
Accumulated Other Comprehensive Income-0.04
Other Equity-0.04
Common Stockholder's Equity-3.22
Total Stockholder's Equity-3.22
Liabilities & Stockholder's Equity8.60
4 historic quarters locked

Sign in to unlock the full Lantern Pharma Inc balance sheet history.

Sign In Create Free Account

About Lantern Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-037971

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.